Global access to Parkinson’s disease treatment
Objective: To examine the availability of PD treatment by country, and analyse differences by national income as defined by the World Bank (high income countries…Opicapone in Parkinson’s disease patients with early/simple motor fluctuations: real-world Spanish data
Objective: To evaluate the efficacy and tolerability of opicapone in patients in Parkinson’s disease (PD) patients with early/simple motor fluctuations (E/S-MF) in the Spanish clinical…Opicapone in Parkinson’s Disease German Patients with Motor Fluctuations: Findings from the OPTIPARK Study
Objective: To evaluate opicapone (OPC) when used in everyday clinical practice conditions to treat Parkinson’s disease (PD) patients with motor fluctuations. Background: OPC proved to…Electroconvulsive therapy for refractory psychiatric symptoms in GBA-related Parkinson disease patient
Objective: This case report aims to highlight the ECT as a promising option on refractory neuropsychiatric manifestations of PD. Background: In GBA-related PD, non-motor symptoms…FINANCIAL COST OF PARKINSON’S DISEASE IN BRAZIL IN THE LAST 10 YEARS
Objective: Analyzing the financial cost of Parkinson's Disease in Brazil in the last 10 years Background: The Parkinson's disease is a neurodegenerative disease that when…Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies
Objective: To characterize and differentiate gait deficits early on in individuals with DLB and PD. Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)…Cognitive reserve in non-demented patients with Parkinson’s disease might protect against amyloid burden effect on cognition
Objective: To evaluate the effect of cognitive reserve (CR) in patients with Parkinson’s disease (PD) without dementia. Background: CR concept is a principal factor explaining…Is cognitive performance related to motor performance among people with Parkinson disease?
Objective: To examine the relationship between cognitive and motor functioning among people with Parkinson disease (PD). Background: PD is a disabling, chronic condition affecting both…Providing Genetic Testing and Genetic Counseling to the Parkinson’s Disease Community: the PD GENEration Pilot Study Experience
Objective: A pilot study was conducted to assess the feasibility of offering widespread genetic testing and counseling to patients with Parkinson’s disease (PD) in the…Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)
Objective: To support the efforts of the Global Parkinson’s Genetics Program (GP2, http://gp2.org/) Monogenic Hub, by developing an easy-to-use online platform for case/family submission. Background:…
- « Previous Page
- 1
- …
- 427
- 428
- 429
- 430
- 431
- …
- 436
- Next Page »